OSSIO receives FDA clearance for bone fixation technology in pediatric surgery


December 09, 2023

1 min learn


We have been unable to course of your request. Please strive once more later. When you proceed to have this challenge please contact [email protected].

Key takeaways:

  • OSSIO introduced FDA clearance of its OSSIOfiber bio-integrative bone fixation expertise to be used in pediatric surgical procedure.
  • The OSSIOfiber implants are indicated to be used in a number of pediatric trauma surgical procedures.

OSSIO has introduced FDA clearance of its OSSIOfiber bio-integrative bone fixation expertise to be used in orthopedic surgical procedure for youngsters and adolescents, in response to a press launch.

The OSSIOfiber implants are indicated for fixation of bone fractures, comminuted fractures, fragments, osteotomies, arthrodesis and bone grafts in pediatric sufferers, in response to the discharge.



Generic FDA News infographic

OSSIO introduced FDA clearance of its OSSIOfiber bio-integrative bone fixation expertise to be used in pediatric surgical procedure.

“With this extremely anticipated clearance, OSSIO enters an vital section of orthopedic surgical procedure, including to our increasing portfolio of OSSIOfiber implants for the fixation of bone fractures and smooth tissue accidents all through the physique in numerous scientific eventualities – now together with the therapy of fractures in youngsters as younger as 2 years previous,” Brian Verrier, CEO of OSSIO, stated within the launch. “Our innovation guarantees to be a gamechanger for clinicians, children and fogeys coping with the problem of fixing fractured bones,” Verrier added.



Source link